• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测小儿肝移植后的理想结局:一项利用机器学习分析对小儿肝移植数据研究进行拓展的探索性研究。

Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data.

作者信息

Wadhwani Sharad Indur, Hsu Evelyn K, Shaffer Michele L, Anand Ravinder, Ng Vicky Lee, Bucuvalas John C

机构信息

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

University of Washington School of Medicine, Seattle Children's Hospital, Seattle, Washington.

出版信息

Pediatr Transplant. 2019 Nov;23(7):e13554. doi: 10.1111/petr.13554. Epub 2019 Jul 22.

DOI:10.1111/petr.13554
PMID:31328849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7980252/
Abstract

Machine learning analyses allow for the consideration of numerous variables in order to accommodate complex relationships that would not otherwise be apparent in traditional statistical methods to better classify patient risk. The SPLIT registry data were analyzed to determine whether baseline demographic factors and clinical/biochemical factors in the first-year post-transplant could predict ideal outcome at 3 years (IO-3) after LT. Participants who received their first, isolated LT between 2002 and 2006 and had follow-up data 3 years post-LT were included. IO-3 was defined as alive at 3 years, normal ALT (<50) or GGT (<50), normal GFR, no non-liver transplants, no cytopenias, and no PTLD. Heat map analysis and RFA were used to characterize the impact of baseline and 1-year factors on IO-3. 887/1482 SPLIT participants met inclusion criteria; 334 had IO-3. Demographic, biochemical, and clinical variables did not elucidate a visual signal on heat map analysis. RFA identified non-white race (vs white race), increased length of operation, vascular and biliary complications within 30 days, and duct-to-duct biliary anastomosis to be negatively associated with IO-3. UNOS regions 2 and 5 were also identified as important factors. RFA had an accuracy rate of 0.71 (95% CI: 0.68-0.74), PPV = 0.83, and NPV = 0.70. RFA identified participant variables that predicted IO-3. These findings may allow for better risk stratification and personalization of care following pediatric liver transplantation.

摘要

机器学习分析能够考虑众多变量,以适应复杂关系,而这些关系在传统统计方法中并不明显,从而更好地对患者风险进行分类。对SPLIT登记数据进行分析,以确定移植后第一年的基线人口统计学因素和临床/生化因素是否能够预测肝移植后3年的理想结局(IO-3)。纳入了在2002年至2006年间接受首次孤立肝移植且有肝移植后3年随访数据的参与者。IO-3定义为3年存活、谷丙转氨酶(ALT)正常(<50)或谷氨酰转肽酶(GGT)正常(<50)、肾小球滤过率(GFR)正常、无非肝移植、无血细胞减少且无移植后淋巴细胞增生性疾病(PTLD)。使用热图分析和随机森林分析(RFA)来描述基线因素和1年因素对IO-3的影响。14名SPLIT参与者中的887名符合纳入标准;334名有IO-3。人口统计学、生化和临床变量在热图分析中未显示出明显信号。RFA确定非白人种族(与白人种族相比)、手术时间延长、30天内的血管和胆道并发症以及胆管对胆管的胆肠吻合术与IO-3呈负相关。美国器官共享联合网络(UNOS)的2区和5区也被确定为重要因素。RFA的准确率为0.71(95%置信区间:0.68-0.74),阳性预测值(PPV)=0.83,阴性预测值(NPV)=0.70。RFA确定了预测IO-3的参与者变量。这些发现可能有助于小儿肝移植后更好地进行风险分层和个性化护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/18fa9c0620a5/nihms-1045700-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/3b6a6c36e766/nihms-1045700-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/f6e36c0ace80/nihms-1045700-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/a74013346e77/nihms-1045700-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/4ae0cbde7f45/nihms-1045700-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/18fa9c0620a5/nihms-1045700-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/3b6a6c36e766/nihms-1045700-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/f6e36c0ace80/nihms-1045700-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/a74013346e77/nihms-1045700-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/4ae0cbde7f45/nihms-1045700-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0572/7980252/18fa9c0620a5/nihms-1045700-f0005.jpg

相似文献

1
Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data.预测小儿肝移植后的理想结局:一项利用机器学习分析对小儿肝移植数据研究进行拓展的探索性研究。
Pediatr Transplant. 2019 Nov;23(7):e13554. doi: 10.1111/petr.13554. Epub 2019 Jul 22.
2
Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.成人高 acuity 肝移植术后吻合口胆道并发症的评估。
JAMA Surg. 2019 May 1;154(5):431-439. doi: 10.1001/jamasurg.2018.5527.
3
Duct-to-duct biliary reconstruction in pediatric split-liver transplantation.小儿劈离式肝移植中的胆管对胆管胆道重建术。
Liver Transpl. 2018 Mar;24(3):432-435. doi: 10.1002/lt.24970. Epub 2018 Feb 12.
4
Improved Outcomes for Liver Transplantation in Patients with Biliary Atresia Since Pediatric End-Stage Liver Disease Implementation: Analysis of the Society of Pediatric Liver Transplantation Registry.自儿童终末期肝病实施以来,胆道闭锁患者肝移植的预后得到改善:对小儿肝移植登记处的分析。
J Pediatr. 2020 Apr;219:89-97. doi: 10.1016/j.jpeds.2019.12.023. Epub 2020 Jan 28.
5
Society of pediatric liver transplantation: Current registry status 2011-2018.小儿肝移植学会:2011-2018 年现行登记状况。
Pediatr Transplant. 2020 Feb;24(1):e13605. doi: 10.1111/petr.13605. Epub 2019 Nov 3.
6
Immunosuppression-Free Life after Pediatric Liver Transplant: A Case-Control Study from the Society of Pediatric Liver Transplant (SPLIT) Registry.小儿肝移植后无免疫抑制的生活:来自小儿肝移植学会(SPLIT)登记处的病例对照研究。
J Pediatr. 2024 Jan;264:113744. doi: 10.1016/j.jpeds.2023.113744. Epub 2023 Sep 17.
7
Long-term outcome of percutaneous transhepatic biliary drainage for biliary strictures following pediatric liver transplantation.经皮经肝胆道引流治疗儿童肝移植后胆道狭窄的长期疗效。
Clin Transplant. 2019 Jun;33(6):e13570. doi: 10.1111/ctr.13570. Epub 2019 May 23.
8
Identifying the futile pediatric liver re-transplant in the PELD era.在儿童终末期肝病模型(PELD)时代识别无效的小儿肝脏再次移植。
Pediatr Transplant. 2010 Dec;14(8):1019-29. doi: 10.1111/j.1399-3046.2010.01400.x. Epub 2010 Sep 23.
9
Prediction of mortality following pediatric heart transplant using machine learning algorithms.使用机器学习算法预测小儿心脏移植后的死亡率。
Pediatr Transplant. 2019 May;23(3):e13360. doi: 10.1111/petr.13360. Epub 2019 Jan 29.
10
Outcome of duct-to-duct vs. Roux-en-Y hepaticojejunostomy biliary anastomoses in below 15-kg pediatric liver transplant recipients.
Pediatr Transplant. 2014 Dec;18(8):831-8. doi: 10.1111/petr.12349. Epub 2014 Sep 3.

引用本文的文献

1
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design.采用以人为本的设计方法,共同为小儿肝移植受者打造一项健康倡导干预措施。
Liver Transpl. 2025 Sep 1;31(9):1143-1153. doi: 10.1097/LVT.0000000000000584. Epub 2025 Feb 21.
2
Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates.肌肉减少症与衰弱:对病理生理学及对肝移植候选者影响的深入分析。
World J Hepatol. 2025 May 27;17(5):106182. doi: 10.4254/wjh.v17.i5.106182.
3
Predicting Organ Rejections for Pediatric Heart Transplantations with a Combined Use of Transplant Registry Data and Electronic Health Records.

本文引用的文献

1
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.肝移植后长期存活的儿科受者肝活检中的慢性移植物损伤证据。
Gastroenterology. 2018 Dec;155(6):1838-1851.e7. doi: 10.1053/j.gastro.2018.08.023. Epub 2018 Aug 23.
2
OPTN/SRTR 2016 Annual Data Report: Liver.OPTN/SRTR 2016 年度数据报告:肝脏。
Am J Transplant. 2018 Jan;18 Suppl 1:172-253. doi: 10.1111/ajt.14559.
3
Tolerance after liver transplantation: Where are we?肝移植后的耐受:我们在哪里?
联合使用移植登记数据和电子健康记录预测小儿心脏移植的器官排斥反应
medRxiv. 2025 May 1:2025.04.29.25326701. doi: 10.1101/2025.04.29.25326701.
4
Machine learning in solid organ transplantation: Charting the evolving landscape.实体器官移植中的机器学习:描绘不断演变的图景。
World J Transplant. 2025 Mar 18;15(1):99642. doi: 10.5500/wjt.v15.i1.99642.
5
Artificial Intelligence in Pediatric Liver Transplantation: Opportunities and Challenges of a New Era.人工智能在小儿肝移植中的应用:新时代的机遇与挑战
Children (Basel). 2024 Aug 15;11(8):996. doi: 10.3390/children11080996.
6
Artificial Intelligence in Liver Diseases: Recent Advances.人工智能在肝脏疾病中的应用:最新进展。
Adv Ther. 2024 Mar;41(3):967-990. doi: 10.1007/s12325-024-02781-5. Epub 2024 Jan 29.
7
Distinct clinical profiles and post-transplant outcomes among kidney transplant recipients with lower education levels: uncovering patterns through machine learning clustering.低教育水平的肾移植受者具有不同的临床特征和移植后结局:通过机器学习聚类揭示模式。
Ren Fail. 2023;45(2):2292163. doi: 10.1080/0886022X.2023.2292163. Epub 2023 Dec 12.
8
Prediction of Outcomes After Heart Transplantation in Pediatric Patients Using National Registry Data: Evaluation of Machine Learning Approaches.利用国家登记数据预测小儿心脏移植后的结局:机器学习方法评估
JMIR Cardio. 2023 Jun 20;7:e45352. doi: 10.2196/45352.
9
Differences between Very Highly Sensitized Kidney Transplant Recipients as Identified by Machine Learning Consensus Clustering.基于机器学习共识聚类分析的超高敏肾移植受者差异。
Medicina (Kaunas). 2023 May 18;59(5):977. doi: 10.3390/medicina59050977.
10
Distinct Phenotypes of Non-Citizen Kidney Transplant Recipients in the United States by Machine Learning Consensus Clustering.通过机器学习共识聚类分析美国非公民肾移植受者的不同表型
Medicines (Basel). 2023 Mar 27;10(4):25. doi: 10.3390/medicines10040025.
Liver Transpl. 2017 Dec;23(12):1601-1614. doi: 10.1002/lt.24845.
4
The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.药物水平变异指数(MLVI)预测肝移植不良结局:一项前瞻性多中心研究。
Am J Transplant. 2017 Oct;17(10):2668-2678. doi: 10.1111/ajt.14276. Epub 2017 Apr 22.
5
Big Data, Predictive Analytics, and Quality Improvement in Kidney Transplantation: A Proof of Concept.大数据、预测分析与肾脏移植质量改进:概念验证
Am J Transplant. 2017 Mar;17(3):671-681. doi: 10.1111/ajt.14099. Epub 2017 Jan 4.
6
The Trouble With Exceptional Exceptions.特殊例外的问题
Am J Transplant. 2016 Nov;16(11):3073-3074. doi: 10.1111/ajt.13920. Epub 2016 Jul 13.
7
Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.非标准例外请求影响小儿肝移植候选者的结局。
Am J Transplant. 2016 Nov;16(11):3181-3191. doi: 10.1111/ajt.13879. Epub 2016 Jun 27.
8
Precision Public Health for the Era of Precision Medicine.精准医学时代的精准公共卫生。
Am J Prev Med. 2016 Mar;50(3):398-401. doi: 10.1016/j.amepre.2015.08.031. Epub 2015 Nov 4.
9
Public Health in the Precision-Medicine Era.精准医学时代的公共卫生
N Engl J Med. 2015 Aug 6;373(6):499-501. doi: 10.1056/NEJMp1506241.
10
The International Heart Transplant Survival Algorithm (IHTSA): a new model to improve organ sharing and survival.国际心脏移植生存算法(IHTSA):一种改善器官分配与生存的新模型。
PLoS One. 2015 Mar 11;10(3):e0118644. doi: 10.1371/journal.pone.0118644. eCollection 2015.